Advertisement

Picture Berlin Partner Health Capital Computational Biology 2022 650x100px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in North America, Europe and Israel or involving organisations from these countries.

Total search results: 7562 | Ordered by Date (descending)
1 2 3 ... 74 75 76  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
GSK–Spero Therapeutics: tebipenem HBr, 202209– license excl $66m upfront + $375m milestones + royalites ww excl JP + some other Asian countries 2022-09-22
Spero Therapeutics–GSK: investment, 202209 purchase $9m shares common stock by GSK in connection with licensing of tebipenem HBr 2022-09-22
Agilent–Scitara: lab informatics, 202209– collab product integration of OpenLab CDS + SLIMS with Scientific Integration Platform SIP + DLX 2022-09-21
Evotec–Adapsyn Biotechnology: drug discovery, 202209– strategic collab €na providing Evotec with accesss to drug-like small molecules for screening 2022-09-21
Nuvisan–Gates Foundation: grant, 202209– grant $9.6m for RnD on non-hormonal contraceptive medicines at Nuvisan ICB GmbH 2022-09-20
Nilogen Oncosystems–Scailyte: personalised medicine, 202209 collab existent developm omics platform for analyzing tumour tissues for I-O developm 2022-09-19
Scailyte–SEVERAL: investment, 202209 financing round Series A CHF6m with Swiss family office + Mirabaud bank + existing investors 2022-09-19
Aignostics–SEVERAL: investment, 202209 financing round Series A €14m led by Wellington Partners 2022-09-15
SparingVision–SEVERAL: investment, 202209 financing round Series B €75m led by Jeito Capital + UPMC Enterprises 2022-09-15
Capstan Therapeutics–SEVERAL: investment, 202209c recently closed financing round Series A 102$m led by Pfizer Ventures 2022-09-14
Novo Group–Microsoft: AI-based drug discovery, 202209 collab strategic combining MS computation services + cloud + AI with Novo RnD + data science 2022-09-12
Pretzel Therapeutics–SEVERAL: investment, 202209 financing round Series A $72.5m led by ARCH Venture Partners + Mubadal Capital 2022-09-12
Pretzel Therapeutics–Ten Bridge Communications: public relations, 202209 service existent Ten Bridge is media contact 2022-09-12
Arsenal Biosciences–SEVERAL: investment, 202209 financing round Series B $220m with new + existing investors 2022-09-06
Abivax–Column Group: investment, 202209 reserved equity capital increase totalling €46.2m incl new + lead investor TCG X 2022-09-02
Abivax–Deep Track Capital: investment, 202209 reserved equity capital increase totalling €46.2m incl new + co-investor Deep Track Capital 2022-09-02
Abivax–Invus Group: investment, 202209 reserved equity capital increase totalling €46.2m incl co-investor Invus 2022-09-02
Abivax–Rockefeller: investment, 202209 reserved equity capital increase totalling €46.2m incl new + co-investor Venrock Healthcare Capital Partners 2022-09-02
Abivax–SEVERAL: investment, 202209 reserved equity capital increase €46.2m with 5.53m new shares at €8.36/share led by TCG X 2022-09-02
Forma Therapeutics–Novo Group: investment, 202209– acquisition $1.1b cash tender of by Novo Nordisk at $20/share 2022-09-01
Novartis–SEVERAL: investment, 202208– spin-off of Sandoz division to be listed on SIX with ADR programme ANNOUNCED 2022-08-25
CIRM–California (govt): grant, 202208 existent $5.5b in funding from state of California for CIRM 2022-08-23
CIRM–ElevateBio: iPSC technology, 202208– collab access to iPSC lines + manufacturing capabilities of ElevateBio for CIRM + its grants projects 2022-08-23
eTheRNA–Novalis LifeSciences: investment, 202208 financing round Series B2 totalling €39m incl existing + lead investor Novalis LifeSciences LLC 2022-08-23
eTheRNA–Omega Funds: investment, 202208 financing round Series B2 totalling €39m incl existing + co-investor Omega Fund 2022-08-23
eTheRNA–PERSON: investment, 202208 financing round Series B2 totalling €39m incl new + co-investor Kenneth Chien 2022-08-23
eTheRNA–SEVERAL: investment, 202208 financing round Series B2 €39m led by existing investor Novalis LifeSciences LLC 2022-08-23
Genome Diagnostics–Eurobio Scientific: investment, 202208– acquisition 100% of GenDx for €135m in cash (net of adjusted cash) 2022-08-17
ChemDiv–Schaffhausen Institute of Technology: drug discovery, 202208– collab strategic establishment of dedicated research group at Jacobs Univ 2022-08-11
Vector BioPharma–Versant Ventures: investment, 202208 company emerges with $30m Series A commitment from Versant Ventures 2022-08-10
B Medical Systems–Azenta: investment, 202208–202210 acquisition $410m upfront + $50m milestones 100% of B Medical from Navis Capital 2022-08-08
Global Blood Therapeutics–Pfizer: investment, 202208– acquisition $5.4b of GBT in cash at $86.5/share ANNOUNCED 2022-08-08
Genmab–BioNTech: cancer immunotherapy, 202208– collab expansion 50/50 cost + profit sharing developm + commercn monospeific antibodies using HexaBody 2022-08-05
3EO Health–Harvard Univ: nucleic acid diagnostics, 202208– license ww excl from Wyss Institute for portable nucleic acid detection technology 2022-08-04
ChemoCentryx–Amgen: investment, 202208– acquisition $3.7b at $52/share ANNOUNCED 2022-08-04
Congenica–GenomOncology: cancer precision diagnostics, 202208– collab developm CE-IVD Precision Oncology Solution using GO Precision Oncology Platform 2022-08-04
F2G Ltd–Cowen: investment, 202208 financing round totalling $70m inc existing + co-investor Cowen Healthcare Investments 2022-08-04
F2G Ltd–Novo Group: investment, 202208 financing round totalling $70m inc existing + co-investor Novo Holdings 2022-08-04
F2G Ltd–SEVERAL: investment, 202208 financing round $70m co-led by new investors Forbion + Sofinnova Partners 2022-08-04
MiroBio–Gilead Sciences: investment, 202208– acquisition $405m in cash of MiroBio by Gilead ANNOUNCED 2022-08-04
Scope Fluidics–Bio-Rad: investment, 202208 acquisition $100m upfront + $70m milestones 100% of Curiosity Diagnostics from Scope Fluidics by Bio-Rad 2022-08-03
Biosynth Carbosynth–Eucodis Bioscience: industrial enzymes, 202208 collab existent for many years 2022-08-02
Eucodis Bioscience–Biosynth Carbosynth: investment, 202208 acquisition of Eucodis by Biosynth Carbosynth 2022-08-02
Mementor–ResMed: investment, 202208 acquisition €na of Mementor DE GmbH by ResMed 2022-08-01
Cleerly–Fidelity: investment, 202207 financing round Series C totalling $223m incl co-lead investor Fidelity Management and Research Company 2022-07-28
Cleerly–Novartis: investment, 202207 financing round Series C totalling $223m incl new + co-investor Novartis 2022-07-28
Cleerly–SEVERAL: investment, 202207 financing round Series C $223m led by T Rowe Price + Fidelity 2022-07-28
Cleerly–T Rowe Price: investment, 202207 financing round Series C totalling $223m incl co-lead investor funds + accounts advised by T Rowe Price 2022-07-28
Replay–ARTIS Ventures: investment, 202207 seed financing round totalling $55m incl co-investor ARTIS Ventures 2022-07-25
Replay–Axial: investment, 202207 seed financing round totalling $55m incl co-investor Axial 2022-07-25
Replay–Consilium: public relations, 202207 service existent by Consilium Strategic Communications 2022-07-25
Replay–DeciBio Ventures: investment, 202207 seed financing round totalling $55m incl co-investor DeciBio Ventures 2022-07-25
Replay–KKR: investment, 202207 seed financing round totalling $55m incl co-lead investor KKR Health Care Strategic Growth Fund II 2022-07-25
Replay–Lansdowne Partners: investment, 202207 seed financing round totalling $55m incl co-investor Lansdowne Partners 2022-07-25
Replay–OMX Ventures: investment, 202207 seed financing round totalling $55m incl co-lead investor OMX Ventures 2022-07-25
Replay–SALT: investment, 202207 seed financing round totalling $55m incl co-investor SALT 2022-07-25
Replay–SEVERAL: investment, 202207 seed financing round $55m led by KKR + OMX Ventures 2022-07-25
One Medical–Amazon: investment, 202207– acquisition $3.9b in cash of 1Life Healthcare Inc by Amazon at $18/share 2022-07-21
Delfi Diagnostics–Allianz: investment, 202207 financing round Series B totalling $225m incl existing + co-investor AV8 Ventures 2022-07-18
Delfi Diagnostics–Brown Advisory: investment, 202207 financing round Series B totalling $225m incl new + co-investor Brown Advisory 2022-07-18
Delfi Diagnostics–Cowen: investment, 202207 financing round Series B totalling $225m incl existing + co-investor Cowen Healthcare Investments 2022-07-18
Delfi Diagnostics–Draper Fisher Jurvetson: investment, 202207 financing round Series B totalling $225m incl new + lead investor DFJ Growth 2022-07-18
Delfi Diagnostics–Foresite Capital: investment, 202207 financing round Series B totalling $225m incl existing + co-investor Foresite Capital 2022-07-18
Delfi Diagnostics–Illumina: investment, 202207 financing round Series B totalling $225m incl existing + co-investor Illumina Ventures 2022-07-18
Delfi Diagnostics–Initiate Ventures: investment, 202207 financing round Series B totalling $225m incl new + co-investor Initiate Ventures 2022-07-18
Delfi Diagnostics–Lilly: investment, 202207 financing round Series B totalling $225m incl new + co-investor Eli Lilly and Co 2022-07-18
Delfi Diagnostics–Menlo Ventures: investment, 202207 financing round Series B totalling $225m incl existing + co-investor Menlo Ventures 2022-07-18
Delfi Diagnostics–Northpond Ventures: investment, 202207 financing round Series B totalling $225m incl existing + co-investor Northpond Ventures 2022-07-18
Delfi Diagnostics–Open Field Capital: investment, 202207 financing round Series B totalling $225m incl new + co-investor Open Field Capital 2022-07-18
Delfi Diagnostics–OrbiMed: investment, 202207 financing round Series B totalling $225m incl existing + co-investor OrbiMed 2022-07-18
Delfi Diagnostics–Osage Partners: investment, 202207 financing round Series B totalling $225m incl existing + co-investor Osage University Partners 2022-07-18
Delfi Diagnostics–Point Field Partners: investment, 202207 financing round Series B totalling $225m incl new + co-investor Point Field Partners 2022-07-18
Delfi Diagnostics–Point72: investment, 202207 financing round Series B totalling $225m incl new + co-investor Point72 2022-07-18
Delfi Diagnostics–PTX Capital: investment, 202207 financing round Series B totalling $225m incl new + co-investor PTX Capital 2022-07-18
Delfi Diagnostics–Rock Springs Capital: investment, 202207 financing round Series B totalling $225m incl existing + co-investor Rock Springs Capital 2022-07-18
Delfi Diagnostics–Samsara BioCapital: investment, 202207 financing round Series B totalling $225m incl existing + co-investor Samsara BioCapital 2022-07-18
Delfi Diagnostics–SEVERAL: investment, 202207 financing round Series B $225m led by DFJ Growth 2022-07-18
Delfi Diagnostics–T Rowe Price: investment, 202207 financing round Series B totalling $225m incl existing + co-investor T Rowe Price Associates Inc 2022-07-18
Delfi Diagnostics–Windham Venture Partners: investment, 202207 financing round Series B totalling $225m incl existing + co-investor Windham VP 2022-07-18
Immunocore–General Atlantic: investment, 202207 private placement totalling $140m incl existing investor General Atlantic 2022-07-18
Immunocore–Rock Springs Capital: investment, 202207 private placement totalling $140m incl existing investor Rock Springs Capital 2022-07-18
Immunocore–RTW Investments: investment, 202207 private placement totalling $140m incl existing investor RTW Investments LP 2022-07-18
Immunocore–SEVERAL: investment, 202207 private placement $140m with 3.73m ADSs/ordinary shares at $37.5/share via PIPE 2022-07-18
Manifold Biotechnologies–Fifty Years: investment, 202207 financing round Series A totalling $40m incl existing + co-investor Fifty Years 2022-07-14
Manifold Biotechnologies–FPV Ventures: investment, 202207 financing round Series A totalling $40m incl new + co-investor FPV Ventures 2022-07-14
Manifold Biotechnologies–Gettylab: investment, 202207 financing round Series A totalling $40m incl existing + co-investor Fast by Gettylab 2022-07-14
Manifold Biotechnologies–Horizon Ventures: investment, 202207 financing round Series A totalling $40m incl new + co-investor Horizon Ventures 2022-07-14
Manifold Biotechnologies–Playground Global: investment, 202207 financing round Series A totalling $40m incl existing + co-investor Playground Global 2022-07-14
Manifold Biotechnologies–Section 32: investment, 202207 financing round Series A totalling $40m incl new + co-investor Section 32 2022-07-14
Manifold Biotechnologies–SEVERAL: investment, 202207 financing round Series A $40m led by new investor Triatomic Capital 2022-07-14
Manifold Biotechnologies–Tencent: investment, 202207 financing round Series A totalling $40m incl new + co-investor Tencent 2022-07-14
Manifold Biotechnologies–Triatomic Capital: investment, 202207 financing round Series A totalling $40m incl new + lead investor Triatomic Capital 2022-07-14
Agomab Therapeutics–OTHER: investment, 202207 financing round Series B extension totalling $40.5m incl existing-investors 2022-07-13
Agomab Therapeutics–Pfizer: investment, 202207 financing round Series B extension totalling $40.5m incl new + lead investor Pfizer Breakthrough GI 2022-07-13
Agomab Therapeutics–SEVERAL: investment, 202207 financing round Series B extension $40.5m led by Pfizer bringing total Series B to $114m 2022-07-13
Agomab Therapeutics–Walleye Capital: investment, 202207 financing round Series B extension totalling $40.5m incl new + co-investor Walleye Capital 2022-07-13
Cergentis–Solvias: investment, 202207 acquisition €na of Cergentis by Solvias 2022-07-12
Glycomine–Little Dog Communications: public relations, 202207 service existent Little Dog is media contact 2022-07-11
Exelixis–Ryvu Therapeutics: STING agonists, 202207– license excl $3m upfront fee to develop STING agonist-based targeted cancer therapies 2022-07-07
Ganymed Robotics–Cathay Capital: investment, 202207 financing round Series B first closing totalling €21m incl lead investor Cathay Health 2022-07-07
1 2 3 ... 74 75 76  next pagenext page



Advertisement

Picture Berlin Partner Health Capital Computational Biology 2022 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture EBD Group ChinaBio Partnering Forum 2022 650x300

» top